Eyes wide shut
- Apple is said to plan upgrades to popular AirPods headphones
- Jose Mourinho hails Scott McTominay after leaving out Paul Pogba against Sevilla
- Govt probing how Khalistani terrorist Jaspal Atwal got India visa: MEA
- De Beers set to mine most diamonds since global financial crisis
- Donald Trump steers right-wing summit CPAC on populist path blazed in Europe
Deal makers are usually smart people who are also prone to hubris. The race to close a major deal often leads to hasty due diligence—and legal tangles later on.
Ranbaxy is a good example. An arbitration court last week asked the pharma company’s former promoters to pay $385 million to Daiichi Sankyo. The Japanese company had complained that it had not been told at the time of the deal about the incipient problems with the US regulators. And, in the liquor industry, Diageo hastily took control of United Spirits from Vijay Mallya. It was only later that the buyer got to know of the soft loans given to other struggling companies in the UB group.
These examples show that even global companies walk into attractive deals with their eyes wide shut. Buyers have to be more careful, but that does not exonerate other players in large corporate deals, such as investment bankers, auditors and the board of directors. What were they doing?